Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022-2024: results from the CLEAR registryEXPERT REVIEW OF ANTI-INFECTIVE THERAPYIF3.82024-09-262PRE
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registryJOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCEIF3.22021-06-0110OAAI
Variation in prophylactic tranexamic acid administration among anesthesiologists and surgeons in orthopedic surgery: a retrospective cohort studyCANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIEIF3.32021-02-164OAAI
Antimicrobial Prophylaxis for Patients Undergoing Cardiac Surgery: Intraoperative Cefazolin Concentrations and Sternal Wound Infections SherylANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52018-11-0119OAAI
Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass-authors' responseJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62018-06-250OA
Limitations of ceftriaxone compared with cefazolin against MSSA: an integrated pharmacodynamic analysisJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62018-04-0417OAAI
Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypassJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62017-12-0816OAAI
Integrated pharmacokinetic-pharmacodynamic modelling to evaluate antimicrobial prophylaxis in abdominal surgeryJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62016-07-0715PREAI
Integrating pharmacokinetics, pharmacodynamics and MIC distributions to assess changing antimicrobial activity against clinical isolates of Pseudomonas aeruginosa causing infections in Canadian hospitals (CANWARD)JOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62013-04-1420OAAI
PHARMACOKINETICS OF CYCLOSPORINE AND TACROLIMUS IN CARDIAC TRANSPLANT PATIENTS WITH DIABETESCANADIAN JOURNAL OF CARDIOLOGYIF5.32012-09-010PREAI
Initial Vancomycin Dosing Protocol to Achieve Therapeutic Serum Concentrations in Patients Undergoing HemodialysisCLINICAL INFECTIOUS DISEASESIF7.32012-05-0928OAAI
The Influence of Sparse Data Sampling on Population Pharmacokinetics: A Post Hoc Analysis of a Pharmacokinetic Study of Morphine in Healthy VolunteersCLINICAL THERAPEUTICSIF3.62012-03-018PREAI
Seizures following cardiac surgery: the impact of tranexamic acid and other risk factorsCANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIEIF3.32011-11-08135OAAI
Preferential Emergence of Reduced Vancomycin Susceptibility in Health Care-Associated Methicillin-Resistant Staphylococcus aureus Isolates during Continuous-Infusion Vancomycin Therapy in an In Vitro Dynamic ModelANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52011-07-0113OAAI
Optimization of meropenem dosage in the critically ill population based on renal function基于肾功能的危重症患者美罗培南剂量优化INTENSIVE CARE MEDICINEIF21.22010-12-0793OA
Pharmacodynamics of empirical antibiotic monotherapies for an intensive care unit (ICU) population based on Canadian surveillance dataJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62010-10-0551OAAI
Support for higher ciprofloxacin AUC24/MIC targets in treating Enterobacteriaceae bloodstream infectionJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62010-06-1763OAAI
The use of antiviral agents for the management of severe influenzaCRITICAL CARE MEDICINEIF62010-04-0152OAAI
Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenzaCANADIAN MEDICAL ASSOCIATION JOURNALIF11.32010-02-16100OAAI
Population Pharmacokinetics of High-Dose, Prolonged-Infusion Cefepime in Adult Critically Ill Patients with Ventilator-Associated PneumoniaANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52009-04-01109OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向